Insulin glulisine
谷赖胰岛素
Report date: 2026/03/31 20:00:21
Base Information
Drug NameInsulin glulisine
Drug Alias Name +[8]
Classification
Mechanisms of Action
Targets
Therapy Area/Indications +[12]
Global Approved Indications
Approved Indications in China
Original Approved Country/Territory
Original Approved Date2004/04/16
Country/Territory +[24]
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesSanofi
China Registration ClassN/A
Develop Information
Active CompaniesSanofiSanofi-Aventis Deutschland GmbhSanofi-Aventis U.S. Llc
Inactive CompaniesUniversity Of Medicine And Dentistry Of New JerseyHealthpartners InstituteNovo Nordisk A/S +[6]
Active Indications
Inactive Indications +[10]